Imax price target raised to $32 from $30 at Roth MKM

Roth MKM analyst Eric Handler raised the firm’s price target on Imax (IMAX) to $32 from $30 and keeps a Buy rating on the shares. The company’s Q4 results were mixed, but the impact on 2025 is largely inconsequential, and more importantly, the management has reiterated its global Box Office guidance of $1.2B, the analyst tells investors in a research note. Roth adds that Box Office performance is starting better than expected thanks to record Chinese New Year results.